60
Participants
Start Date
June 30, 2010
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
BMS-823778
Capsules, Oral, 2 mg, once daily, 28 days
BMS-823778
Capsules, Oral, 10 mg, once daily, 28 days
BMS-823778
Capsules, Oral, 20 mg, once daily, 28 days
Placebo
Capsules, Oral, 0 mg, once daily, 28 days
Local Institution, Brisbane
National Clinical Research - Richmond, Inc., Richmond
National Clinical Research - Norfolk, Inc., Norfolk
Sterling Research Grp, Ltd., Cincinnati
Pra International, Lenexa
Osborne Research Center, Little Rock
Cetero Research - San Antonio, San Antonio
Local Institution, Winnipeg
Local Institution, Mount Pearl
Local Institution, London
Local Institution, Drummondville
Local Institution, Montreal
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY